Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I tried and the MF MMs partial me with 327 shares, and then fill below me. What the f****k is that. Well at least it’s open for 60 days , so hopefully it’ll fill and rip.
I agree with your analysis. I have shares of both ELTP and Teva at the moment. With that being said, I have multitudes more capital in Elite than Teva. I am also considering DVAX, when it fills the gap around 6 dollars.
Keep on buying my fellow longs. The setting in this range has been quite a gift to accumulate over the past few weeks. May be small to some, but I have been able to accumulate roughly 30k shares over the past few weeks, all 0.091 and under....Amen to that
Of course, enjoying these low 9's, as we wait for news
https://titanchronicle.com/2019/04/24/substance-abuse-treatment-market-to-reach-a-valuation-of-us-16000-mn-by-the-end-of-2026/
Elite and its partner Glenmark mentioned in an article for the growing market within Substance Abuse Treatment
Thanks for all the .090xx’s this morning. Averaged to just about 10 now ??
86,000 shares were bought by Rachel King (Director) on 3/27/19, at a price of $ 0.53. Could be telling of the upside....
Interested to see how these conferences/talks go the next few weeks.
I tend to think NVAX will get approval on the secondary endpoints for the RSV vaccine, but will need some post-marketing data to validate. RSV is a very serious condition in these infants, and preventing the most serious complications is a huge stride in the right direction.
For NanoFlu, yes they will need further funding, but I see no reason why the data will not turn out positive. I believe that these conferences will secure funding, or interest in a partnership/buyout.
Any controlled substance that is schedule I or II, is given a quota (Adderall is Sched II). With that being said, allotment of quota to each company depends on the amount applied for, current market demand and manufactures, and prediction into the next year (for predicted manufacturers and demand). Manufacturing requests must be in by May 1st, to my knowledge, but amendments may be made at any time.
Thanks for the Insider Financial recap
see Nasdaq's post about QA on the form 144
"A person filing a Form 144 must have a bona fide intention to sell the shares within a reasonable time after the filing of a Form 144. However, the filing of Form 144 does not prevent the filer from changing their decision about selling their shares or obligate the filer to sell their shares."
He is not required to. Just should have intent to do so when filing
Within 90 days, you say?
Could be very telling to a sharp increase in price that he would like to sell into. Isradipine data? Adderall ER? Market Launch of Adderall IR? SunGen-Antibiotic news?
Hmmm
I would like to see the details of the marketing agreement, however I do think it is great news and think we will see the agreement once the other product is approved. Lannett is a very reputable company with higher revenues than Glenmark USA. Additionally as others have stated, I think we were in a great position for negotiations due to their overreaction to their trouble last year.
Thank you for the information Jimmy, your insight is valuable.
Some birdies are starting to chirp about how they are going to like their isradiseeds for better controlled movements
Great unbiased post and very informative. I share the same sentiment with much of what you say. Enjoy reading your posts on the board.
The correspondence could have been one of the CTO’s we’ve had of recent. I wouldn’t be surprised, if so.
4 replies all gone? Any idea what they said? And is there any truth that he must release SequestOx update by Monday/Tuesday?
Name// Shares Held// Position Value// % of Total
Holdings// Outstanding
Shares Owned// Investment Style
Caskey (Davis S) 263.7 K $26.6 K 0.30 0.03% Low
Dash (Barry H) 1.4 M $146.4 K1.63 0.17% Low
Gabelli Funds, LLC 1.0 M $100.0 K1.12 0.11% Low
Hakim (Nasrat A) 12.6 M $2.4 M 14.20 2.72% N/A
Narine (Jeenarine) 19.7 M $3.7 M 22.13 4.24% N/A
Nigalaye (Ashok G) 48.1 M $9.0 M 54.06 10.36% N/A
Pfeifer (Eugene M.) 267.2 K $28.1 K 0.30 0.03% Low
Plassche (Douglas) 529.8 K $55.6 K 0.60 0.06% Low
Ward (Carter Julian CPA)3.5 M $371.0 K3.97 0.42% Low
Whitnell (Jeffrey A) 1.4 M $141.5 K1.57 0.16% Low
It has been pointed out to me that these figures are slightly outdated and not totally inclusive, some members holding much more than these figures, plus the convertibles.
Yes, quite a substantial amount, along with the other Board Members and various employees.
Thank you for the information from the 10q....I just pulled information from my broker, must not have been the updated O/S, so I'm sorry for that. Interesting, but I'll admit I'm wrong, when I'm wrong.
Either way 48.1 million shares held for this long is nothing to scoff at.
(1) Shares Held
(2) Position Value
(3) % of Total Outstanding Shares Owned
"Nigalaye (Ashok G) (1) 48.1 M (2) $9.0 M (3) 10.34%"
-supporting evidence
I would love to but my notes will not all fit on this page and it is not my duty to inform you of the information I find pertinent. We are on opposing sides, as is quite obvious, but I believe you will be found to be incorrect, if you do in fact believe what you write.
I do not have millions at this point of my career, but what I do like to find is undervalued, legitimate companies and invest a good chunk of my money and let it sit until the negative pressure is finally alleviated, and get a very nice return.
After all the non-branded products come to market, there will be more than enough fuel to provide for the company's financial needs and a much higher revenue and resultant profit stream. Share price will multiply very quickly even without a buyout or merger immediately... hence why M&As often happen before the best goods come out to play--so the M&A benefit the larger company at a lower premium. The longer the wait, the higher the price goes, provided things continue as they finally are now.
Good things are to come!
-Docta Out
Chart Further Strengthened .... Closed back above the 10 day MA. I believe some strong positive momentum is to be upon us in the coming days-weeks.
Multiple pieces of news are to be coming, on many fronts, from the different "baskets" we hold. The "eggs" are almost ready for hatching in each of their baskets.
For me this does not matter, for a day or swing trader perhaps, but me no. This company will most likely be bought out, or lesser likely, merged with in they very near future. It was my belief that this would be done by the end of 2018 or early 2019, but I think I am about a year off in my calculations, due to some hiccups that we have had. However, we have also diversified our portfolio much more than I anticipated before, which may garner a better price than I thought previously. My price estimate with a 1 billion share count is 0.60-0.70 cents, when all said and done, without the golden egg Sequest. However with SequestOx, I believe we furnish a price easily above 1.00 per share.
Only time will tell. All I know is I have faith in this company and have accumulated all I could, especially with all the new types of products, partnerships, and names becoming associated with Elite.
The best of luck to those with the thick skin, on the board, or even reading and not posting ;). We will be rewarded. 10-11 cents is highly undervalued at this point and time, in my opinion, and suppression of the price can only occur while volume is low. The tipping point will be soon, as interest in "little" old Elite is increasing.
Thank you for reminding me of the EPIC product recapture, that was quite far back in my notes.
No problem ted. Our time will come very soon. 2 other key points without delving too much into the technical charting aspect.
Short interest is down about 74% and the accumulation distribution line is mountainous, just to accompany all the other recent and pending events and terrific charts on multiple time frames.
2020 vision
My apologies, it was a semantic error on my end, Nigalaye owns over 10.74% of the outstanding shares.
YJ- No problem my friend. Have been a loyal long for going on 5 years now. Glad to finally see things coming to fruition on all fronts. Anything that deals with beuarocracy takes time, in which Pharma is heavily intertwined.
No2- I keep an eye on the board here and there, but can’t deal with most of the banter. When there is relevance, that is when I listen to the chirping and sift through more research. Dig deeper into the Press Releases and you’ll see gold.
Roc- I’ve only been reiterating what others have said and seen, with some insight in the workings of the industry. I appreciate it and will do my best.
Can you elaborate please
Greetings, No2 and the ELTP board.
It has been a while since I have logged in and perused the board, but I must say I absolutely love your posts (as well as a few other natives).
Here is what I have to say:
The Lincoln Park Funding has terms of share price they may execute at, which even the first "step" is above where we stand. I believe the first price allowed is 15 cents if memory serves me correct, and the rest climb all the way to 40 cents. So, the price must have some sort of catalyst coming if Lincoln were to agree to the terms--why sign a meaningless contract.
Next we have our givens....Multiple pending aNDAs, multiple approved aNDAs awaiting transfer, reformulated Sequest and pending meeting with the FDA.
Then we have on our business front:
1. Employees are taking a substantial amount of their pay in stock, whether options or otherwise.
2. Employees are tightly gripping their shares. FOR INSTANCE Nigalaye (Ashok G)
owns 9 million dollars worth of ELTP or10.74% of the company, alone.
4. We have a tremendous deal with Glenmark that puts us on the distribution map --- big time.
5. We have an established partnership with Dr. Reddy's and aided the FDA when they needed a company to produce it in the shortage. Which through Dr. Reddy's it opens avenues for communication, hearsay in the industry, and future distribution/manufacturing needs.
6. I'm inclined to believe there is "behind the scenes" action, with the new gentleman, who was involved in the buyout of EPIC....Who was also affiliated with Humanwell--- and Humanwell being affiliated with SunGen our other developing partnership, if my memory serves me correctly.
7. We have many CTO's expiring over the next few years.
Seems like the dominos are almost done being set up.
2020 vision IMO. This guy right here has been loading for ages and am now positive from averaging down and accruing all I could under 9.
Love all ya fellow longs
Ah, makes more sense. Thank you for the follow up. Relatively new moderator for the board? Liking the new faces here
Just an observation.
AMMX’s iHub page has never been without a chart on the main page. Now in its place it shows something about validating if it is the correct symbol, as the symbol does not exist. This is in concert with beautiful chart action and great news over the past few months. Seemingly a coordinated effort to keep attention off of AMMX or deter new investors.
*Edit...chart is now back up, after my b***hing*
IMO a run like 2014 is in the making ladies and gentlemen
Interesting... we are on the verge of a large breakout and the chart on the home page disappears
Why is everyone saying CDL, SeaQuesTox, unELITE, etc.?
Afraid proper spellings will populate google searches, draw attention, and in turn put the shorts at risk?
Elite will have its day, the clock just needs to strike 12, and when it does, 1 hell of a ride will ensue next. All it takes is for the first domino to fall into place, which could be any of the pending news we await.
NDA
ANDAs
and Confidential Treatment Orders, oh my
Or cup and handle, either way, drooling
S.M.O.G. -sweet mother
That chart looks fantastic, inverted head and shoulders??
E-Trade showing a 1M buy after hours at .02569. 4:12 PM
Green tomorrow, breakout Monday. Red tomorrow, more churning.
Long term charts all poised for breakout.
1 Year - daily chart - mirroring first 6 months of this year, where we had a 7 fold breakout, with exceedingly high and increasing volumes.
1 Year - weekly chart - extremely strong support found with the 50 period MA, as well as the Middle of the Bollinger Bands, and again mirroring the first 6 months of this year (breakout with consolidation in a flag pattern). MACD crossing into the positive once again with the RSI at a cool 51/52.
1 Year - monthly chart - Bollinger Bands extremely tight and pps pressing the upper band on increasing volumes. MACD to cross into the positive region next month.
Strongest short term resistance at the 7-8 cent line, following the range we've been trading.
GLTA